First, they enable phagocytic uptake of tumor cells by antigen-presenting cells, leading to subsequent antigen presentation to CD4+ and CD8+ T cells, stimulating the anti-tumor adaptive immune response [16]. The gene discussed is CD8A; the disease is neoplasm.